American Society of Hematology (ASH) 2019 Annual Meeting Dec 82019 Dec 8, 2019 Supporting Materials Phase 1 of REGN5458 (BCMAxCD3) in Relapsed/Refractory Multiple Myeloma 359.1 KB Phase 1 of Pozelimab (REGN3918) in Normal Healthy Volunteers 415.8 KB Study Design: Phase 2 of REGN1979 (CD3xCD20) in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL) 148.4 KB REGN1979 in patients with R/R B-NHL – ASH 2019 data update 991.9 KB
Phase 1 of REGN5458 (BCMAxCD3) in Relapsed/Refractory Multiple Myeloma 359.1 KB Phase 1 of Pozelimab (REGN3918) in Normal Healthy Volunteers 415.8 KB Study Design: Phase 2 of REGN1979 (CD3xCD20) in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (B-NHL) 148.4 KB REGN1979 in patients with R/R B-NHL – ASH 2019 data update 991.9 KB